Conexeu Sciences Inc. (CNXU) vs Nordicus Partners Corporation (NORD)

Conexeu Sciences Inc. and Nordicus Partners Corporation are both Biotechnology companies. Conexeu Sciences Inc. and Nordicus Partners Corporation are of similar size ($65.4M and $63.2M). Across the 9 metrics below, Nordicus Partners Corporation leads on 8 and Conexeu Sciences Inc. on 1.

Valuation

Metric CNXU NORD Biotechnology median
P/E n/m n/m 10.26
P/S n/m 81.31 9.18
P/B 9.64 1.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 83.80 8.98
Earnings yield (29.81%) (8.24%) (34.89%)
Free cash flow yield (18.82%) (6.25%) (24.52%)

Profitability

Metric CNXU NORD Biotechnology median
Gross margin — 70.18% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (458.40%) (8.06%) (50.12%)
Return on assets (354.37%) (6.80%) (45.60%)
Return on invested capital (234.60%) (4.43%) 0.00%

Growth

Metric CNXU NORD Biotechnology median
Revenue growth (TTM) — (71.68%) 6.26%
EPS growth (last fiscal year) (342.80%) 30.58% 29.88%
Revenue growth, 5-year CAGR — (71.31%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CNXU NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.31 0.18 4.89
Net debt to EBITDA 1.23 0.00 1.01

Dividend

Metric CNXU NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNXU NORD Biotechnology median
Market cap 65.36m 63.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack